Method of Housing and Transfer and Experimental Autoimmune Encephalomyelitis: An Experimental Study on C57BL/6

AUTHORS

Maryam Soleimani 1 , Seyed Behnamedin Jameie 2 , 3 , * , Soodeh Razeghi Jahromi 4 , Akram Alizadeh 5 , Mahdieh Kerdari 2

1 Department of Basic Sciences, University of Social Welfare and Rehabilitation Sciences, Tehran, IR Iran

2 Department of Medical Basic Sciences, Faculty of Allied Medicine, Iran University of Medical Sciences, Tehran, IR Iran

3 Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, IR Iran

4 Multiple Sclerosis Research Center, Neuroscience Institute, Sina Hospital, Tehran University of Medical Sciences, Tehran, IR Iran

5 Department of Tissue Engineering, School of Advanced Medical Technologies, Tehran University of Medical Sciences, Tehran, IR Iran

How to Cite: Soleimani M, Jameie S B, Razeghi Jahromi S, Alizadeh A, Kerdari M. Method of Housing and Transfer and Experimental Autoimmune Encephalomyelitis: An Experimental Study on C57BL/6, Thrita. 2014 ; 3(4):e22187. doi: 10.5812/thrita.22187.

ARTICLE INFORMATION

Thrita: 3 (4); e22187
Published Online: December 1, 2014
Article Type: Research Article
Received: July 20, 2014
Revised: November 5, 2014
Accepted: November 12, 2014
Crossmark

Crossmark

CHEKING

READ FULL TEXT
Abstract

Background: Multiple Sclerosis (MS) is an autoimmune inflammatory demyelinating disease of human central nervous system. Although experimental autoimmune encephalomyelitis (EAE) is the most commonly used method to induce MS, there are unexpected results in the modeling outcomes, which led to inappropriate clinical score scaling. Recent studies focused on the possible factors that may affect the final outcome of EAE modeling. Some of these factors were observed and discussed in our experiment on C57BL/6 model.

Objectives: The present research was carried out to find the possible effects of environmental factors, including transfer, handling, housing, and dark-light cycle on EAE modeling scoring.

Materials and Methods: Twenty female mice (C57BL/6) were used that divided into two groups (n = 10) by random. The routine method of MS induction in mammals was used in both groups. Following induction, animals of group one were placed in a separated room with the least local translocation and handling, whereas animals of the second group were placed in the same room as the other animals with normal local allocation as others. The animals were observed and scored using routine clinical scoring for EAE.

Results: Our data showed that the EAE induction in group one was significantly more successful than group two (with the mean score > 3).

Conclusions: Although the EAE is still a scientific method to induce MS in rodents, it requires more attention to environmental factors that might influence the result. The mechanisms of these factors are unknown, but it seems that the role of housing environment should be taken into consideration.

Keywords

Housing Encephalomyelitis Animal

Copyright © 2014, Thrita. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.

1. Background

Multiple Sclerosis (MS) is an autoimmune inflammatory demyelinating disease of human central nervous system. Experimental study on different aspects of MS in animal models dates back to the first half of the 20th century (1). The first animal model was adult monkeys that were immunized with rabbit brain extracts (2). At that time, the clinical statement was called acute disseminated encephalomyelitis, a term that was later changed to experimental allergic or autoimmune encephalomyelitis (EAE) (3, 4). Different procedures, including active or passive immunization are used to induce EAE. Currently the routine procedure is to immunize with myelin proteins like myelin basic protein (MBP), and adjuvants that can be passively transferred to animals by CD4+ T cells (5). Active immunization in the mouse involves immunizing the mouse with spinal cord homogenate or purified myelin peptides. Passive immunization involves adoptively transferring sensitized lymph node cells from immunized animal in naïve mice. Whether passive or active, most EAE immunization protocols result in acute EAE (6). There are many factors contributing in the outcome of modeling, including sex, age, type of animals, anti-myelination proteins, site and method of injection, as well as immunization procedures. To our knowledge, the animals, including rat, mice, and monkey were used for modeling. The most used one is female C57BL/6 mice and the more common procedure is immunization with MOG 35–55 in Complete Freund’s adjuvant (CFA), which induce monophasic or a chronic disease (7). Although same or near to same procedures were used by researchers, during recent years certain modification were done for better results in the modeling of MS induction. To achieve better results, some researchers mainly focused on gender and age of the animals; others believed that the injection procedures may affect the outcome, while some other certain factors may exists, which could affect the outcome of modeling. There are unexpected consequences in modeling that led to undesirable clinical scores; recently the role of environmental factors received more attention. As they can influence experimental outcome, environmental conditions should recognize and monitor during experiment. The present research was carried out to find the possible effects of local transfer and housing (8).

2. Objectives

The present research was performed to find out the possible effects of environmental factors, including animal transfer, handling, housing, and dark-light cycle on EAE modeling scoring.

3. Materials and Methods

3.1. Induction of EAE

We applied mostly the same procedures as other studies stated. Twenty female mice, 5–8 weeks old, (C57BL/6, 19.4 g) were obtained from Pasteur Institute of Iran. The animals were divided randomly into two groups (n = 10). The animals were immunized subcutaneously with 200 μg of MOG 35–55 peptide (Alexis, Switzerland), emulsified in Complete Freund’s adjuvant (CFA), and supplemented with 5 mg/mL of Mycobacterium tuberculosis (Sigma-Aldrich, USA). Then, they received intraperitoneal injections of 400 ng pertussis toxin (Sigma-Aldrich, USA) at the time of immunization, and 48 hours later (9, 10). Following induction, animals of group one were placed in separated room with the least local transfer, and animals of the second group were placed in the room with other experimental animals having normal local transfer and conditions.

3.2. Clinical EAE Score

To approve the onset and stage of progression of the disease, the standard scoring system cited elsewhere was used (6). Based on this method, clinical signs of no symptoms, distal weakness or spastic tail and completely limp tail, bilateral partial hind-limb paralysis, complete hind-limb and unilateral partial forelimb paralysis, moribund, and dead were scored 0, 1, 2, 3, 4, and 5, respectively. We confirmed the EAE model by Luxol Fast Blue staining in optic nerve (Figures 1 and 2).

Figure 1. LFB in Optic nerve to Confirm of Model
LFB in Optic nerve to Confirm of Model

Luxol Fast Blue staining used for rate of demyelination showed significant differences among groups including group 1 (A) and group 2 (B).

Figure 2. Histogram of Demyelination in Optic Nerve
Histogram of Demyelination in Optic Nerve

Significant difference between EAE (group 1) and EAE (group 2).

3.3. Tissue Preparation

Perfusion and fixation was done transcardially via left ventricle by aldehyde solutions. Optic nerve was removed and postfixed in the same solution overnight. After that, the optic nerve was exposed to tissue processing and in turn paraffin embedding. By using rotatory microtome, coronal sections of 4 µ thickness, were prepared. To study the myelination, Luxol Fast Blue staining with Nissl contra staining was used. The total surface of demyelinated regions was calculated by Infinity Software (Version 4.4.0).

3.4. Statistical Analysis

By using SPSS V 21(SPSS Inc., Chicago, USA), data were analyzed and presented as mean ± SEM. All mean differences were considered significant if P < 0.05.

4. Results

Based on routine clinical scoring for EAE, the animals were observed and scored. The scores of the animals of the first group were arranged as follows: score 1(days 10–12, n = 2), score 2 (days 11–13, n = 3), score 3 (days 12–15, n = 2), score 4 (days 13–17, n = 2), and score 5 (days 15–20, n = 1). And in the second group, they were 5, 5, 1, 1, and 0, respectively (Figure 3). Loss of weight, which was considered as one of the important markers for confirmation of mice model was weighted daily after immunization. The maximum mean score for the EAE in group 1 was significantly lower than the EAE of animals in group 2 (P < 0.05, 17 ± 0.9 vs. 13 ± 0.41, respectively). Our data showed that EAE induction was significantly more successful in the animals of the group one with mean score of more than 2, compared to group two animals (P < 0.05).

Histogram Shows Scoring Rate in Animals of Group one and Two (P &lt; 0.05)
Figure 3. Histogram Shows Scoring Rate in Animals of Group one and Two (P < 0.05)

5. Discussion

Our results showed that two environmental factors, including method of housing and transfer of the animals influence the outcome of modeling. There are also other reports that emphasize on the role of certain factors that might change the outcome of EAE modeling, including the age and sex of the animals. Other studies like Teuscher et al., was more focused on the method and site of injection (8). Other researchers showed that the season, dark and light cycle, and the time of injection might be important factors that affect the scoring outcome (9). However, Perez-Nievas et al. showed that the EAE modeling is unpredictable and the effect of stress on EAE onset and severity depends on the duration and time of application of the stress protocol and the underlying mechanisms (11). The literature review showed that there are only a few reports concerning the role of animal housing and transfer on EAE outcome. Our data showed the importance of these two factors. We believe that separating housing of the animals after EAE induction may protect the animals from environmental air pollution of the general animal room area that may activate the immune system of the models. It is known that any hyperactivation of immune system might interfere with modeling. Maybe like other autoimmune diseases, exposure to different types of bacteria rendered mice refractory to disease induction (12, 13). Other environmental agents, including trauma, solar radiation exposure, temperature, stress, and toxins, are discussed in terms of their relevance to MS and EAE (14). In addition, the style of animal transfer before and after injection could affect the outcome of EAE modeling via changing the physiological conditions of the animals. We think that a constant place, especially after injection may keep the physiological haemostasis. EAE still is a scientific method to induce MS in rodents, with more attention to certain factors that might influence the result. The mechanisms of the impact of these factors are unknown, but it seems that the role of bacteria should be considered.

Acknowledgements

Footnotes

References

  • 1.

    Lindsey JW. EAE: history, clinical signs, and disease course. Experimental Models of Multiple Sclerosis. : 2005; : 1 -9

  • 2.

    Rivers TM, Sprunt DH, Berry GP. Observations on Attempts to Produce Acute Disseminated Encephalomyelitis in Monkeys. J Exp Med. 1933; 58(1) : 39 -53 [PubMed]

  • 3.

    Freund J, Stern ER, Pisani TM. Isoallergic encephalomyelitis and radiculitis in guinea pigs after one injection of brain and Mycobacteria in water-in-oil emulsion. J Immunol. 1947; 57(2) : 179 -94 [PubMed]

  • 4.

    Mix E, Meyer-Rienecker H, Hartung HP, Zettl UK. Animal models of multiple sclerosis--potentials and limitations. Prog Neurobiol. 2010; 92(3) : 386 -404 [DOI][PubMed]

  • 5.

    Pettinelli CB, McFarlin DE. Adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice after in vitro activation of lymph node cells by myelin basic protein: requirement for Lyt 1+ 2- T lymphocytes. J Immunol. 1981; 127(4) : 1420 -3 [PubMed]

  • 6.

    McCombe PA, Harness J, Pender MP. Effects of cyclosporin A treatment on clinical course and inflammatory cell apoptosis in experimental autoimmune encephalomyelitis induced in Lewis rats by inoculation with myelin basic protein. J Neuroimmunol. 1999; 97(1-2) : 60 -9 [PubMed]

  • 7.

    Steinman L. Multiple sclerosis: a two-stage disease. Nat Immunol. 2001; 2(9) : 762 -4 [DOI][PubMed]

  • 8.

    Teuscher C, Bunn JY, Fillmore PD, Butterfield RJ, Zachary JF, Blankenhorn EP. Gender, age, and season at immunization uniquely influence the genetic control of susceptibility to histopathological lesions and clinical signs of experimental allergic encephalomyelitis: implications for the genetics of multiple sclerosis. Am J Pathol. 2004; 165(5) : 1593 -602 [DOI][PubMed]

  • 9.

    Pluchino S, Quattrini A, Brambilla E, Gritti A, Salani G, Dina G, et al. Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis. Nature. 2003; 422(6933) : 688 -94 [DOI][PubMed]

  • 10.

    Swanborg RH. Experimental autoimmune encephalomyelitis in rodents as a model for human demyelinating disease. Clin Immunol Immunopathol. 1995; 77(1) : 4 -13 [PubMed]

  • 11.

    Perez-Nievas BG, Garcia-Bueno B, Madrigal JL, Leza JC. Chronic immobilisation stress ameliorates clinical score and neuroinflammation in a MOG-induced EAE in Dark Agouti rats: mechanisms implicated. J Neuroinflammation. 2010; 7 : 60 [DOI][PubMed]

  • 12.

    Lehmann D, Ben-Nun A. Bacterial agents protect against autoimmune disease. I. Mice pre-exposed to Bordetella pertussis or Mycobacterium tuberculosis are highly refractory to induction of experimental autoimmune encephalomyelitis. J Autoimmun. 1992; 5(6) : 675 -90 [PubMed]

  • 13.

    Emerson MR, Gallagher RJ, Marquis JG, LeVine SM. Enhancing the ability of experimental autoimmune encephalomyelitis to serve as a more rigorous model of multiple sclerosis through refinement of the experimental design. Comp Med. 2009; 59(2) : 112 -28 [PubMed]

  • 14.

    Constantinescu CS. Environmental influences in experimental autoimmune encephalomyelitis. Experimental Models of Multiple Sclerosis. : 2005; : 523 -46

  • COMMENTS

    LEAVE A COMMENT HERE: